株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のハイコンテントスクリーニング市場、機器別(細胞画像化・分析システム)・用途別(一次・二次スクリーニング、目標識別・検証、毒性研究、化合物プロファイリング)、ソフトウェア・サービス:予測

High Content Screening Market by Instruments (Cell Imaging & Analysis System), by Applications (Primary & Secondary Screening, Target Identification & Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018

発行 MarketsandMarkets 商品コード 296131
出版日 ページ情報 英文 151 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
世界のハイコンテントスクリーニング市場、機器別(細胞画像化・分析システム)・用途別(一次・二次スクリーニング、目標識別・検証、毒性研究、化合物プロファイリング)、ソフトウェア・サービス:予測 High Content Screening Market by Instruments (Cell Imaging & Analysis System), by Applications (Primary & Secondary Screening, Target Identification & Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018
出版日: 2014年02月11日 ページ情報: 英文 151 Pages
概要

近年、創薬の様々な段階におけるハイコンテントスクリーニングの導入は増加傾向にあります。世界のハイコンテントスクリーニング市場は、2013年には3億6,220万米ドルの規模であり、以降CAGR11.2%の伸び率で、2018年には6億1,580万米ドルの規模に達する見込みとなっています。市場の成長を促す要因としては、創薬の初期段階において毒性レベルを確認する必要性、細胞を使った研究に対する政府の支援、ならびに強化された情報ソリューションおよび機能が改善された画像分析機器の導入などが挙げられます。

当レポートでは、世界のハイコンテントスクリーニング市場を取り上げ、機器別・用途別・エンドユーザー別・地域別に市場の現状と見通しについて調査分析するとともに、競合環境、主要企業のプロファイルをまとめるなど、概略以下の構成でお届けいたします。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • イントロダクション
  • 市場区分
  • 市場動態
    • 市場発展促進要因
      • 創薬の初期段階において毒性レベルを確認する必要性
      • 細胞を使った研究における政府資金およびベンチャー資本投資が市場成長を促進
      • 強化された情報ソリューションおよび改善された画像分析機器の投入
    • 市場発展阻害要因
      • ハイコンテントスクリーニングシステムの高いコストは市場成長を阻害する可能性がある
    • 市場機会
      • 開発業務受託機関(CRO)はHCSサービス提供の大きな機会を有する
      • 一次スクリーニングにおけるハイコンテントスクリーニングの導入
      • オーダーメイド医療におけるハイコンテントスクリーニングの応用
      • HCS市場における確信を促すための協力
    • 課題
      • ハイコンテントスクリーニングの知識を有する熟練した専門家の不足
  • 市場シェア分析

第4章 製品タイプ別

  • イントロダクション
  • 機器
    • 細胞画像化・分析システム
    • フロー血球計算器
  • 消耗品
    • 試薬・試料キット
    • マイクロプレート
    • その他の消耗品
  • ソフトウェア
  • サービス

第5章 用途別

  • イントロダクション
    • 目標識別・検証
    • 一次スクリーニング・二次スクリーニング
    • 毒性試験
    • 化合物プロファイリング
    • その他の用途

第6章 エンドユーザー別

  • 製薬会社・バイオテクノロジー企業
  • 学術・政府機関
  • 開発業務受託機関(CRO)

第7章 地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア
  • ROW(その他地域)

第8章 競合環境

  • イントロダクション
  • 新製品発表
  • 事業拡張
  • 合意、提携、パートナーシップ
  • 買収

第9章 企業プロファイル(概要、財務実績、製品・サービス、戦略、最近の動き)

  • Becton, Dickinson and Company
  • Cell Signaling Technology, Inc.
  • Danaher Corporation
  • Ge Healthcare(General Electric Companyの子会社)
  • Genedata Ag
  • Merck Kgaa
  • Perkinelmer, Inc.
  • thermo Fisher Scientific, Inc.
  • Thorlabs, Inc.
  • 横河電機

図表

目次
Product Code: BT 2227

The global high content screening market is a technology-driven market and is marked by the 'Threat of Obsolescence,' wherein technologies as well as their adoption by end users changes very rapidly. Pharmaceutical and biotechnology companies as well as academic and government institutes are increasingly focusing on using high content screening as a powerful research tool in drug discovery. The high content screening software market is the fastest-growing segment in the high content screening market. In high content screening, the accuracy of the results obtained depends on image analysis and data management software. In recent years, enhanced image analysis and data management solutions have been introduced, but there is scope for these solutions to be further improvised to provide improved results. Many of the key players in the high content screening instruments market are collaborating with software companies to offer products with better software. For instance, in November 2010, PerkinElmer collaborated with Glencoe Software, Inc. to integrate Columbus Scope, a cellular imaging software solution for microscopy. With the data sharing facility, Columbus Scope helps in data management in high content screening.

In the coming years, Asian countries are expected to witness a high growth. These regions offer an array of opportunities for growth and are expected to be the new revenue pockets for high content screening. This region offers a high growth potential as compared to mature markets such as the U.S. Growth in the Asian market is spurred by government support for the development of innovative screening technologies and rising demand for outsourcing of drug discovery services. For instance, in September 2013, Global Health Innovative Technology Fund (GHIT Fund), granted $5.7 million to six global partnerships to support the R&D activities of these partnerships in the area of various infectious diseases like tuberculosis, malaria, and Chagas disease. Such fundings are expected to boost the growth of the high content screening market.

The global high content screening market is competitive and all the existing players in this market are engaged in developing new and advanced products to maintain their market shares.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help the firms in garnering a greater market share. Firms purchasing this report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping a greater market share.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios and services offered by the top players in the high content screening market. The report analyzes the high content screening market by application across geographies

Product Development/Innovation: Detailed insights on research and development activities and new product launches in the high content screening market

Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes promising applications of the high content screening market by product across geographies

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the high content screening market

Competitive Assessment: In-depth assessment of market shares, strategies, products and services, and distribution networks in the high content screening market

Table of Contents

1. Introduction

  • 1.1. Objectives of the Study
  • 1.2. Report Description
  • 1.3. Markets Covered
  • 1.4. Stakeholders
  • 1.5. Market Scope
  • 1.6. Research Methodology
    • 1.6.1. Market Size Estimation
    • 1.6.2. Market Crackdown and Data Triangulation
    • 1.6.3. Market Share
    • 1.6.4. Key Data Points From Primary Sources
    • 1.6.5. Key Data Points From Secondary Sources

2. Executive Summary

3. Market Overview

  • 3.1. Introduction
  • 3.2. Market Segmentation
  • 3.3. Market Dynamics
    • 3.3.1. Drivers
      • 3.3.1.1. Need For Determining Level of Toxicity in the Early Stages of Drug Discovery
      • 3.3.1.2. Government Funding and Venture Capital Investments in Cell-Based Research Will Drive the Market Growth
      • 3.3.1.3. Introduction of Enhanced Informatics Solutions and Improved Image Analysis Instruments
    • 3.3.2. Restraints
      • 3.3.2.1. High Cost of High Content Screening Systems May Hinder the Market Growth
    • 3.3.3. Opportunities
      • 3.3.3.1. Contract Research Organizations Have Significant Opportunities To Provide HCS Services
      • 3.3.3.2. Adoption of High Content Screening For Primary Screening
      • 3.3.3.3. Application of High Content Screening in Personalized Medicine
      • 3.3.3.4. Collaborations To Increase Innovation in the HCS Market
    • 3.3.4. Challenges
      • 3.3.4.1. Shortage of Knowledgeable and Skilled Professionals For High Content Screening
  • 3.4. Market Share Analysis

4. By Product Type

  • 4.1. Introduction
  • 4.2. Instruments
    • 4.2.1. Cell Imaging and Analysis Systems
    • 4.2.2. Flow Cytometers
  • 4.3. Consumables
    • 4.3.1. Reagents & Assay Kits
    • 4.3.2. Microplates
    • 4.3.3. Other Consumables
  • 4.4. Software
  • 4.5. Services

5. By Application

  • 5.1. Introduction
    • 5.1.1. Target Identification and Validation
    • 5.1.2. Primary Screening and Secondary Screening
    • 5.1.3. Toxicity Studies
    • 5.1.4. Compound Profiling
    • 5.1.5. Other Applications

6. By End Users

  • 6.1. Pharmaceutical and Biotechnology Companies
  • 6.2. Academia and Government Institutes
  • 6.3. Contract Research Organizations (CRO)

7. Geographic Analysis

  • 7.1. Introduction
  • 7.2. North America
  • 7.3. Europe
  • 7.4. Asia
  • 7.5. ROW

8. Competitive Landscape

  • 8.1. Introduction
  • 8.2. New Product Launch
  • 8.3. Expansions
  • 8.4. Agreements, Collabarations, Partnerships
  • 8.5. Acquisitions

9. Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)*

  • 9.1. Becton, Dickinson and Company
  • 9.2. Cell Signaling Technology, Inc.
  • 9.3. Danaher Corporation
  • 9.4. Ge Healthcare (Subsidiary of General Electric Company)
  • 9.5. Genedata Ag
  • 9.6. Merck Kgaa
  • 9.7. Perkinelmer, Inc.
  • 9.8. thermo Fisher Scientific, Inc.
  • 9.9. Thorlabs, Inc.
  • 9.10. Yokogawa Electric Corporation

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.

List of Tables

  • Table 1: Global Market, By Product Type, 2011-2018 ($Million)
  • Table 2: HCS Products Market, By Geography, 2011-2018 ($Million)
  • Table 3: The Global High Content Screening Instruments Market, By Type, 2011-2018 ($Million)
  • Table 4: HCS Instruments Market, By Geography, 2011-2018 ($Million)
  • Table 5: Cell Imaging and Analysis HCS Systems Market, By Geography, 2011-2018 ($Million)
  • Table 6: HCS Flow Cytometers Market, By Geography, 2011-2018 ($Million)
  • Table 7: Global HCS Consumables Market, By Type, 2011-2018 ($Million)
  • Table 8: HCS Consumables Market, By Geography, 2011-2018 ($Million)
  • Table 9: HCS Reagents and Assay Kits Market, By Geography, 2011-2018 ($Million)
  • Table 10: HCS Microplates Market, By Geography, 2011-2018 ($Million)
  • Table 11: HCS Other Consumables Market, By Geography, 2011-2018 ($Million)
  • Table 12: HCS Software Market, By Geography, 2011-2018 ($Million)
  • Table 13: HCS Services Market, By Geography, 2011-2018 ($Million)
  • Table 14: Global HCS Applications Market, By Type, 2011-2018 ($Million)
  • Table 15: HCS Applications Market, By Geography, 2011-2018 ($Million)
  • Table 16: HCS Target Identification and Validation Market, By Geography, 2011-2018 ($Million)
  • Table 17: HCS Primary and Secondary Screening Market, By Geography, 2011-2018 ($Million)
  • Table 18: HCS Toxicity Studies Market, By Geography, 2011-2018 ($Million)
  • Table 19: HCS Compound Profiling Market, By Geography, 2011-2018 ($Million)
  • Table 20: HCS Other Applications Market, By Geography, 2011-2018 ($Million)
  • Table 21: Global Market, By End User, 2011-2018 ($Million)
  • Table 22: HCS End Users Market, By Geography ($Million)
  • Table 23: Pharmaceutical and Biotechnology Companies HCS Market, By Geography, 2011-2018 ($Million)
  • Table 24: Academia and Government Institutes HCS Market, By Geography, 2011-2018 ($Million)
  • Table 25: Contract Research Organization HCS Market, By Geography, 2011-2018 ($Million)
  • Table 26: HCS Product Market, By Geography, 2011-2018 ($Million)
  • Table 27: North America: Market, By Product Type, 2011-2018 ($Million)
  • Table 28: North America: HCS Instruments Market, By Type, 2011-2018 ($Million)
  • Table 29: North America: HCS Consumables Market, By Type, 2011-2018 ($Million)
  • Table 30: North America: Market, By Application Type, 2011-2018 ($Millions)
  • Table 31: North America: Market, By End User, 2011-2018 ($Million)
  • Table 32: Europe: Market, By Product Type, 2011-2018 ($Million)
  • Table 33: Europe: HCS Instruments Market, By Type, 2011-2018 ($Million)
  • Table 34: Europe: HCS Consumables Market, By Type, 2011-2018 ($Million)
  • Table 35: Europe: Market, By Application Type, 2011-2018 ($Million)
  • Table 36: Europe: Market, By End User, 2011-2018 ($Million)
  • Table 37: Asia: Market, By Product Type, 2011-2018 ($Million)
  • Table 38: Asia: HCS Instruments Market, By Type, 2011-2018 ($Million)
  • Table 39: Asia: HCS Consumables Market, By Type, 2011-2018 ($Million)
  • Table 40: Asia: Market, By Application, 2011-2018 ($Million)
  • Table 41: Asia: Market, By End User, 2011-2018 ($Million)
  • Table 42: ROW: Market, By Product Type, 2011-2018 ($Million)
  • Table 43: ROW: HCS Instruments Market, By Type, 2011-2018 ($Million)
  • Table 44: ROW: HCS Consumables Market, By Type, 2011-2018 ($Million)
  • Table 45: ROW: Market, By Application, 2011-2018 ($Million)
  • Table 46: ROW: Market, By End User, 2011-2018 ($Million)
  • Table 47: New Product Launch, 2011-2013
  • Table 48: Expansions, 2011-2013
  • Table 49: Agreements, Partnerships, Collabarations, 2011-2013
  • Table 50: Acquisitions, 2011-2013

List of Figures

  • Figure 1: Forecast Model
  • Figure 2: Market Size Estimation Methodology
  • Figure 3: Market Crackdown & Data Triangulation Methodology For the HCS Market
  • Figure 4: Global Market, By Product, 2013-2018 ($Million)
  • Figure 5: HCS Market, By Geography, 2013-2018 ($Million)
  • Figure 6: Market Segmentation
  • Figure 7: Market Dynamics
  • Figure 8: Global HCS Instruments Market Share, By Key Players, 2013
  • Figure 9: HCS Products Market, By Geography, 2013
  • Figure 10: Key Growth Strategies, HCS Market, 2011-2013
Back to Top